Michigan Medicine Updates in Lupus 2022
Format: 4 videos + 5 pdfs, size: 811 MB
Course Audience: rheumatologist, primary care physican
Overview:
Description
This course will discuss the basics of lupus management and then broaden to discuss management of lupus nephritis, including a discussion of new FDA approved medications. It will also cover efforts to address disparities in lupus care and outcomes and the latest research ongoing to improve our treatment of lupus patients.Target Audience
This activity is appropriate for:
House Officers, Medical Students, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, PhysiciansIn the fields of:
General Medicine, Internal Medicine, Other Healthcare Professions, RheumatologyLearning Objectives
At the end of this activity, participants should be able to:
- identify the role of hydroxychloroquine in standard of care lupus management.
- describe the role of immunosuppressants and which ones to choose in SLE.
- list the barriers to proper care in lupus patients.
- differentiate the patients that my benefit from voclosporin and belimumab for lupus nephritis.
- research new therapies in the pipeline and how they may benefit patients with SLE.
Course Syllabus (PDF Format)
Beyond Cyclophosphamide, Treating Lupus Nephritis in the New Millennium (PDF Format)Beyond Cyclophosphamide, Treating Lupus Nephritis in the New Millennium (Video TS Format)Getting to a Cure the Role of Research in SLE (PDF Format)Getting to a Cure the Role of Research in SLE (Video TS Format)Social Determinants of Health and Lupus Care (PDF Format)Social Determinants of Health and Lupus Care (Video TS Format)What is Lupus (Really) and How Do We Treat it (PDF Format)What is Lupus (Really) and How Do We Treat it (Video TS Format)